Notícias · Recifes

CAR T cell therapy leads to 10-year remissions in B-cell lymphoma patients

After a median follow-up of 10 years, more than one-third of patients with large B-cell lymphoma and nearly half of patients with follicular lymphoma who received a single infusion of tisagenlecleucel—the CAR T-cell therapy developed by Carl June, MD, that would go on to become t

Admin Recifes 15/07/2026 2

New COPD injection targets proteins in body to reduce inflammation

For the first time, patients have received a new injection for chronic obstructive pulmonary disease (COPD), thanks to research by King's College London.

Admin Recifes 15/07/2026 2

Radioligand therapy for HER2-positive cancers enters human trials for the first time

The McGill University Health Centre (MUHC) is the first site in the world to launch a first-in-human phase 1 clinical trial evaluating a novel radioligand therapy for HER2-positive cancers, including certain types of breast cancer.

Admin Recifes 15/07/2026 2

Healthy gut microbes in 6-week-old infants linked to lower risk of malaria during first ye

In a small study in the Democratic Republic of Congo, 6-week-old infants with healthy gut microbiomes were less likely to contract malaria in their first year of life. While the study is preliminary, it suggests the possibility that treatments such as probiotics could protect aga

Admin Recifes 15/07/2026 2

First 3D views of human cone opsins reveal how daylight vision reacts so fast

The retina of the human eye contains 6–7 million cone cells. These cells contain light-sensitive proteins known as cone opsins. They enable us to perceive our surroundings in detail in daylight. They allow us to see the world in thousands of colors: red strawberries, green leaves

Admin Recifes 15/07/2026 2

First potential probiotic treatment for lupus identified by researchers

Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, have found a link between a bacterium in the gut microbiome (ecosystem) and lupus that could lead to more effective treatment of the disease, described in a study published

Admin Recifes 15/07/2026 3

Dual human antibodies stop lethal Nipah and Hendra even after infection begins

An international research team led by investigators in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai has developed the first fully human monoclonal antibody cocktail shown to provide complete protection against lethal Nipah and Hendra virus infecti

Admin Recifes 15/07/2026 2

Intracellular mechanisms promote tumor survival during hypoxia

Northwestern Medicine scientists have, for the first time, described the underlying mechanisms that regulate how cells rapidly change gene expression in response to hypoxia, a key feature of many treatment-resistant tumors, according to a recent study published in Science Advance

Admin Recifes 15/07/2026 2

Scratching that bug bite might feel good at first but science explains why it's a bad idea

You've likely heard it since childhood: Don't scratch that bug bite or rash, you'll make it worse. But why would something that feels so good be bad?

Admin Recifes 15/07/2026 2

New button battery technology shows promise, but swallowing remains an emergency

A recently released child-safety battery designed to reduce the danger from accidental ingestion is showing significant promise, but medical professionals should not alter their management protocols yet. In the first peer-reviewed scientific assessment of the recently commerciali

Admin Recifes 15/07/2026 3

Breastfeeding may help babies sleep longer by age one, challenging formula feeding claims

The World Health Organization (WHO) recommends exclusive breastfeeding for the first six months of life because of its many proven benefits, including protection against infections and support for healthy long-term development. However, perceptions that breastfed infants sleep le

Admin Recifes 15/07/2026 2

Thirty years later: A reappraisal of Alzheimer's disease risk in Japanese APOE-e4 homozygo

Researchers at Niigata University have conducted the first comprehensive reappraisal in nearly 30 years of the risk of Alzheimer's disease (AD) associated with APOE-e4 homozygosity (e4*4) in the Japanese population. Their findings, published in the journal Molecular Neurodegenera

Admin Recifes 15/07/2026 2

Acompanhe as Notícias da Recifes